Valmark Advisers’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$328K Hold
1,486
﹤0.01% 596
2026
Q1
$439K Sell
1,486
-9
-0.6% -$2.67K 0.01% 496
2025
Q4
$408K Sell
1,495
-31
-2% -$8.42K 0.01% 483
2025
Q3
$412K Sell
1,526
-10
-0.7% -$2.72K 0.01% 475
2025
Q2
$423K Hold
1,536
0.01% 471
2025
Q1
$407K Sell
1,536
-5
-0.3% -$1.23K 0.01% 460
2024
Q4
$358K Buy
1,541
+22
+1% +$5.06K 0.01% 476
2024
Q3
$335K Hold
1,519
0.01% 479
2024
Q2
$299K Sell
1,519
-8
-0.5% -$1.65K 0.01% 475
2024
Q1
$329K Buy
1,527
+58
+4% +$12.2K 0.01% 440
2023
Q4
$309K Buy
+1,469
New +$313K 0.01% 415

Other funds holding CME

Valmark Advisers's CME Position: Q2 2026 in Review

Valmark Advisers held its CME Group (CME) position steady in Q2 2026 at 1,486 shares worth $328K. The position accounts for ﹤0.01% of the portfolio, ranked #596.

Valmark Advisers first reported a position in CME in Q4 2023 and has held it in 11 quarters since. The position peaked at $439K in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Valmark Advisers held 1,486 shares of CME Group worth $328K as of Q2 2026.
  • Valmark Advisers left its CME Group share count unchanged in Q2 2026.
  • CME Group made up ﹤0.01% of Valmark Advisers's portfolio in Q2 2026, its #596 holding.
  • Valmark Advisers first reported a position in CME Group in Q4 2023 and has held it in 11 quarters since.
  • Valmark Advisers's CME Group position peaked at $439K in Q1 2026.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Valmark Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.